Streptomyces as Biofactories: A Bibliometric Analysis of Antibiotic Production Against Staphylococcus aureus
Authors:
- Pablício Pereira CardosoPCPablício Pereira Cardoso
- Kamila Brielle Pantoja VasconcelosKVKamila Brielle Pantoja Vasconcelos
- Sámia Rocha PereiraSPSámia Rocha Pereira
- Rafael Silva CardosoRafael Silva Cardoso
- Ramillys Carvalho de SouzaRSRamillys Carvalho de Souza
- Lucas Francisco da Silva NogueiraLNLucas Francisco da Silva Nogueira
- Suelen Fabrícia dos Santos BentesSBSuelen Fabrícia dos Santos Bentes
- Vivaldo Gemaque de AlmeidaVAVivaldo Gemaque de Almeida
- Silvia Katrine Rabelo da SilvaSSSilvia Katrine Rabelo da Silva
Preprint
- 26 June 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Infections caused by Staphylococcus aureus pose significant public health challenges, particularly due to antibiotic-resistant strains like MRSA. In this context, Streptomyces, a genus known for producing natural antibiotics, emerges as a promising source for novel therapeutic agents. This study conducted a bibliometric analysis of scientific literature (2015–2024) on Streptomyces as antibiotic biofactories against S. aureus, aiming to identify publication trends, collaborative networks, and emerging research areas. Using the Web of Science database, searches were performed with descriptors ("Streptomyces" AND "Staphylococcus aureus"), including original articles and reviews in English. Data were analyzed with VOSviewer and Biblioshiny to visualize collaborative networks, keyword co-occurrences, and trends. A total of 755 articles from 3,705 authors were analyzed, highlighting significant collaboration (98.7%). Publications showed marked growth, particularly in Microbiology (27.67%), Pharmacology and Pharmacy (21.51%), and Biotechnology and Applied Microbiology (20.50%). China and India led in publication volume, whereas the United States exhibited the highest citation impact. Key emerging research topics include biosynthesis and metabolic optimization, antimicrobial activity and bioprospecting, mechanisms of antibiotic action and bacterial resistance, and genomic analyses. Research into Streptomyces for antibiotic production against S. aureus demonstrates continuous expansion and global interest, emphasizing the importance of international collaboration and multidisciplinary approaches. Future studies should intensify exploration of biodiverse environments, genetic engineering applications, and combinatorial strategies to effectively address antimicrobial resistance.Keywords
All Related Versions
- Version 1, 2025-06-26, Preprints
- Published version: Antibiotics, 14 (10), 983.
This publication has 49 references indexed in Scilit:
- Shifting research paradigms in landscape ecology: insights from bibliometric analysisLandscape Ecology, 2025
- Metabolic engineering of Streptomyces to enhance the synthesis of valuable natural productsEngineering Microbiology, 2022
- How to conduct a bibliometric analysis: An overview and guidelinesJournal of Business Research, 2021
- Recent advances in heterologous expression of natural product biosynthetic gene clusters in Streptomyces hostsCurrent Opinion in Biotechnology, 2021
- Research on Industry 4.0 and on key related technologies in Vietnam: A bibliometric analysis using ScopusLearned Publishing, 2021
- Streptomyces sp. M54: an actinobacteria associated with a neotropical social wasp with high potential for antibiotic productionAntonie van Leeuwenhoek, 2021
- A putative mechanism underlying secondary metabolite overproduction by Streptomyces strains with a 23S rRNA mutation conferring erythromycin resistanceApplied Microbiology and Biotechnology, 2020
- The action mechanism of daptomycinBioorganic & Medicinal Chemistry, 2016
- Antibiotics produced by StreptomycesThe Brazilian Journal of Infectious Diseases, 2012
- Software survey: VOSviewer, a computer program for bibliometric mappingScientometrics, 2009